Cancer remains a major global health challenge, marked by complexity, heterogeneity, and resistance to conventional therapies. The evolving field of bioelectronics, an interdisciplinary domain at the interface of biology and electronics, offers promising innovations in cancer diagnosis, treatment, monitoring, and prognosis. Recent advances include the development of wearable and implantable devices, microfluidic chips, and bio-hybrid technologies, such as biobots and lab-on-a-chip platforms. These tools support non-invasive diagnostics, personalized treatment strategies, and continuous patient monitoring with improved sensitivity and specificity. Furthermore, bioelectronic systems enhance drug delivery and immunotherapy by leveraging electric fields, nanoparticles, and programmable electronic interfaces. Integration with artificial intelligence and tissue engineering further augments their potential. While significant progress has been made, challenges such as biocompatibility, long-term stability, and clinical scalability remain. Nonetheless, bioelectronics represents a transformative frontier in oncology, offering a futuristic pathway toward smarter, more adaptive, and patient-centric cancer care. This review examines how bioelectronic devices, particularly biosensors, integrate biological recognition elements with electronic systems to enable the real-time detection of cancer biomarkers, facilitating early and precise intervention.


扫码关注我们
求助内容:
应助结果提醒方式:

